No sides. Just data.

We compare what the media report with what the data say

Home › Today's contrasts › Health

Health · 2 outlets

La Usal desarrolla una estrategia de nanomedicina contra el cáncer de mama HER2 positivo

Origin La Razón · 19/10 17:00 → 2 outlets in 1 h

Who appearsEva Martín del Valle 2Martín Del Valle 2Hospital UniversitarioUniversidad de Salamanca

Nothing to flag

All 2 outlets report the same figures and names, and there are no claims to check against official data. If that changes, the story comes back to the front page.

How each outlet tells it

Who does not report it

29 outlets

National outlets from the same country that published those days and have no piece in this story. Not an accusation: it may be an editorial choice.

20minutosABCAntena 3 NoticiasASCinco DíasCOPEEl ConfidencialEl DebateelDiario.esEl EspañolEl HuffPostEl MundoEl PaísEl PluralEl SaltoESdiarioEuropa PressExpansióninfoLibreInformativos TelecincoLa InformaciónlaSextaLa VanguardiaLibertad DigitalMaldita.esNewtralOKDIARIOOnda CeroThe Objective

Who reports it and how

2 stories
  1. La Razón 19/10 17:00 · National La Usal desarrolla una estrategia de nanomedicina contra el cáncer de mama HER2 positivo
  2. La Gaceta de Salamanca 19/10 18:02 · Local Nueva estrategia de nanomedicina con potencial para tratar el cáncer de mama

More contrasts in health

19/10/2026 17:00 – 19/10/2026 18:02 UTC · Analysis basis: texto completo · Methodology · Automatically produced, reviewable content. Headlines and short excerpts quoted with a link to the original outlet. The analysis is our own.